New Blood Test Predicts Prognosis for Advanced Prostate Cancer Patients
The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.
Read MorePosted by Andy Lundin | Dec 11, 2024 | Molecular Diagnostics, Prostate |
The AR-ctDETECT test identifies circulating tumor DNA in advanced prostate cancer patients, providing critical insights for prognostication.
Read MorePosted by Andy Lundin | Nov 12, 2024 | Molecular Diagnostics, Prostate |
A genetic variant in the PSA gene may help improve prostate cancer diagnostics by distinguishing between aggressive and non-aggressive types.
Read MorePosted by Andy Lundin | Oct 7, 2024 | Prostate |
A study shows that measuring CTCs at the time of metastatic prostate cancer diagnosis can predict survival and guide treatment decisions.
Read MorePosted by Chris Wolski | Sep 10, 2024 | Prostate |
A new prostate cancer screening method could help better predict which patients need to undergo a biopsy, reducing unnecessary procedures.
Read MorePosted by Andy Lundin | Aug 30, 2024 | Prostate |
GRAIL’s Galleri multi-cancer early detection test demonstrates strong performance in preferentially identifying aggressive prostate cancers.
Read More